These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2577402)

  • 21. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure.
    Matsumoto A; Hirata Y; Kakoki M; Nagata D; Momomura Si; Sugimoto T; Tagawa H; Omata M
    Clin Sci (Lond); 1999 Jan; 96(1):67-74. PubMed ID: 9857108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
    Ando R; Matsuda O; Miyake S; Yoshiyama N
    Nephron; 1988; 50(3):225-8. PubMed ID: 2976122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal.
    Wang T; Cheng HH; Heimbürger O; Chen C; Bergström J; Lindholm B
    Kidney Int; 2001 Aug; 60(2):513-9. PubMed ID: 11473634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of changes in intravascular volume on atrial size and plasma levels of immunoreactive atrial natriuretic peptide in uremic man.
    Cannella G; Albertini A; Assanelli D; Ghielmi S; Poiesi C; Gaggiotti M; Sandrini M; Visioli O; Maiorca R
    Clin Nephrol; 1988 Oct; 30(4):187-92. PubMed ID: 2975201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive hormones in uremic patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Li PK; Woo KS; Lui SF; Leung JC; Law E; Nicholls MG
    Clin Nephrol; 1991 May; 35(5):218-23. PubMed ID: 1830251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurohumoral responses to a single haemodialysis in chronic renal patients.
    Uusimaa P; Huttunen K; Ruskoaho H; Linnaluoto M; Ikäheimo M
    Acta Physiol Scand; 1999 Jan; 165(1):25-31. PubMed ID: 10072093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
    Hasegawa K; Matsushita Y; Inoue T; Morii H; Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of atrial natriuretic peptide in different diseases of the nose.
    Yue WL
    J Otolaryngol; 1989 Jun; 18(4):181-3. PubMed ID: 2525627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure.
    Anderson JV; Raine AE; Proudler A; Bloom SR
    J Endocrinol; 1986 Aug; 110(2):193-6. PubMed ID: 2943848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.
    de Châtel R; Makó J; Tóth M; Barna I; Lang RE
    Int Urol Nephrol; 1991; 23(2):177-83. PubMed ID: 1830872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure.
    Takagi T; Nishikawa M; Inada M
    Endocr J; 1993 Apr; 40(2):257-61. PubMed ID: 7951512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed decrease in plasma levels of atrial natriuretic peptide during cold hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Nielsen AL; Lindberg BF
    Nephron; 1994; 68(4):427-32. PubMed ID: 7870226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choline levels in human peritoneal dialysate.
    Hjelle JT; Welch MH; Pavlina TM; Webb LE; Mockler D; Miller MA; Steidley KR; Olsson PJ; Horvath FJ; Mahon L
    Adv Perit Dial; 1992; 8():30-2. PubMed ID: 1361811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypophosphatemia in infants on continuous ambulatory peritoneal dialysis.
    Roodhooft AM; Van Hoeck KJ; Van Acker KJ
    Clin Nephrol; 1990 Sep; 34(3):131-5. PubMed ID: 2225564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of atrial natriuretic peptide in human blood.
    Yamaji T; Ishibashi M; Takaku F; Sato F; Kamoi K; Nakaoka H; Fujii J; Hasegawa K; Morii H
    Jpn J Med; 1987 May; 26(2):207-11. PubMed ID: 2957532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraperitoneal infusion of dialysate: a possible cause of increased plasma atrial natriuretic peptide levels.
    Calzavara P; Da Rin G; Salandin V; Amici GP; Galardi N; Vianello A; Bocci C; da Porto A
    Nephron; 1993; 63(3):361-2. PubMed ID: 8446282
    [No Abstract]   [Full Text] [Related]  

  • 40. [Atrial natriuretic peptide (ANP) in cardiologic laboratory diagnosis].
    Woloszczuk W; Hartter E
    Z Med Lab Diagn; 1989; 30(1):31. PubMed ID: 2524139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.